These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19075051)

  • 1. Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes.
    Kalia V; Miglani R; Purnapatre KP; Mathur T; Singhal S; Khan S; Voleti SR; Upadhyay DJ; Saini KS; Rattan A; Raj VS
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1427-33. PubMed ID: 19075051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
    Mathur T; Singhal S; Khan S; Bhateja P; Pandya M; Rattan A; Bhatnagar PK; Upadhyay DJ; Fatma T
    J Chemother; 2008 Aug; 20(4):420-7. PubMed ID: 18676219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis.
    Mathur T; Kalia V; Barman TK; Singhal S; Khan S; Upadhyay DJ; Rattan A; Raj VS
    Int J Antimicrob Agents; 2013 Jan; 41(1):36-40. PubMed ID: 23142085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria.
    Swaney SM; Aoki H; Ganoza MC; Shinabarger DL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3251-5. PubMed ID: 9835522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria.
    Mathur T; Bhateja P; Pandya M; Fatma T; Rattan A
    Int J Antimicrob Agents; 2004 Oct; 24(4):369-73. PubMed ID: 15380263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay.
    Murray RW; Schaadt RD; Zurenko GE; Marotti KR
    Antimicrob Agents Chemother; 1998 Apr; 42(4):947-50. PubMed ID: 9559817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
    Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1996 Mar; 40(3):799-801. PubMed ID: 8851617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.
    Hoellman DB; Lin G; Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1148-50. PubMed ID: 12604559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
    Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats.
    Naruganahalli KS; Shirumalla RK; Bansal V; Gupta JB; Das B; Ray A
    Eur J Pharmacol; 2006 Sep; 545(2-3):167-72. PubMed ID: 16899241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.
    Mulazimoglu L; Drenning SD; Yu VL
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2428-30. PubMed ID: 8891159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid-dependent function and structure adaptation of ribosomes in a Staphylococcus epidermidis strain exhibiting linezolid dependence.
    Kokkori S; Apostolidi M; Tsakris A; Pournaras S; Stathopoulos C; Dinos G
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4651-6. PubMed ID: 24890589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes.
    Aoki H; Ke L; Poppe SM; Poel TJ; Weaver EA; Gadwood RC; Thomas RC; Shinabarger DL; Ganoza MC
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1080-5. PubMed ID: 11897593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions.
    Shinabarger DL; Marotti KR; Murray RW; Lin AH; Melchior EP; Swaney SM; Dunyak DS; Demyan WF; Buysse JM
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2132-6. PubMed ID: 9333037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
    Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1143-7. PubMed ID: 12604558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
    Das B; Rudra S; Yadav A; Ray A; Rao AV; Srinivas AS; Soni A; Saini S; Shukla S; Pandya M; Bhateja P; Malhotra S; Mathur T; Arora SK; Rattan A; Mehta A
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4261-7. PubMed ID: 16054358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
    Jorgensen JH; McElmeel ML; Trippy CW
    Antimicrob Agents Chemother; 1997 Feb; 41(2):465-7. PubMed ID: 9021209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.
    Schwameis R; Fille M; Manafi M; Zeitlinger M; Sauermann R
    Res Microbiol; 2012 Apr; 163(3):157-60. PubMed ID: 22210435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.
    Rybak MJ; Cappelletty DM; Moldovan T; Aeschlimann JR; Kaatz GW
    Antimicrob Agents Chemother; 1998 Mar; 42(3):721-4. PubMed ID: 9517963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.